Kymera Therapeutics, Inc. (KYMR) Reports Material Event to SEC
Filing Details Kymera Therapeutics, Inc. (NASDAQ:KYMR) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event. Market Context…
Read more
